Collaboration Agreements with industry partners with prioritised assets will be put into place with University of Birmingham (Sponsor). The University will enter into separate agreements with associated third-parties. This includes, but is not limited to:
- Chief Investigator
- National Coordinating Centres
- Participating UK Centres
- Vendors providing clinical trial services
- Other academic collaborators for adjunctive scientific studies
- Other industry partners with prioritised assets
There will be two agreements made with the industry partners: a start-up agreement and a main collaboration agreement.
The start-up agreement and associated budget will include all start-up activity costs associated with the initial work-up in preparation for inclusion of the asset into the trial and should be executed rapidly with any amendments restricted to administrative changes only.
The main Collaboration Agreement between the parties will be negotiated once the start-up agreement is finalised. A commitment to execute both agreements in an expedited fashion is imperative to ensure the smooth running of the trial. A videoconference every two weeks between the legal teams of the Sponsor and industry partner will be scheduled following acceptance of an asset into the trial.